Targeting the MLL complex in castration-resistant prostate cancer

被引:156
作者
Malik, Rohit [1 ,2 ]
Khan, Amjad P. [1 ,2 ]
Asangani, Irfan A. [1 ,2 ]
Cieslik, Marcin [1 ,2 ]
Prensner, John R. [1 ,2 ]
Wang, Xiaoju [1 ,2 ]
Iyer, Matthew K. [1 ,2 ]
Jiang, Xia [1 ,2 ]
Borkin, Dmitry [2 ]
Escara-Wilke, June [1 ,2 ]
Stender, Rachell [1 ,2 ]
Wu, Yi-Mi [1 ,2 ]
Niknafs, Yashar S. [1 ]
Jing, Xiaojun [1 ,2 ]
Qiao, Yuanyuan [1 ,2 ]
Palanisamy, Nallasivam [1 ,2 ,3 ]
Kunju, Lakshmi P. [1 ,2 ,4 ]
Krishnamurthy, Pranathi M. [1 ]
Yocum, Anastasia K. [1 ]
Mellacheruvu, Dattatreya [2 ,5 ]
Nesvizhskii, Alexey I. [1 ,2 ,5 ]
Cao, Xuhong [1 ,6 ]
Dhanasekaran, Saravana M. [1 ,2 ]
Feng, Felix Y. [1 ,7 ,8 ]
Grembecka, Jolanta [2 ]
Cierpicki, Tomasz [2 ]
Chinnaiyan, Arul M. [1 ,2 ,4 ,5 ,6 ,8 ]
机构
[1] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Henry Ford Hlth Syst, Dept Urol, Detroit, MI USA
[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[7] Univ Michigan, Radiat Oncol, Ann Arbor, MI 48109 USA
[8] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
ANDROGEN-RECEPTOR; INCREASED SURVIVAL; MENIN; GENE; EXPRESSION; PROTEINS; ANTIANDROGEN; CELLS;
D O I
10.1038/nm.3830
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistance to androgen deprivation therapies and increased androgen receptor (AR) activity are major drivers of castrationresistant prostate cancer (CRPC). Although prior work has focused on targeting AR directly, co-activators of AR signaling, which may represent new therapeutic targets, are relatively underexplored. Here we demonstrate that the mixed-lineage leukemia protein (MLL) complex, a well-known driver of MLL fusion-positive leukemia, acts as a co-activator of AR signaling. AR directly interacts with the MLL complex via the menin-MLL subunit. Menin expression is higher in CRPC than in both hormone-naive prostate cancer and benign prostate tissue, and high menin expression correlates with poor overall survival of individuals diagnosed with prostate cancer. Treatment with a small-molecule inhibitor of menin-MLL interaction blocks AR signaling and inhibits the growth of castration-resistant tumors in vivo in mice. Taken together, this work identifies the MLL complex as a crucial co-activator of AR and a potential therapeutic target in advanced prostate cancer.
引用
收藏
页码:344 / +
页数:11
相关论文
共 53 条
[1]   Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer [J].
Arredouani, Mohamed S. ;
Lu, Bin ;
Bhasin, Manoj ;
Eljanne, Miriam ;
Yue, Wen ;
Mosquera, Juan-Miguel ;
Bubley, Glenn J. ;
Li, Vivian ;
Rubin, Mark A. ;
Libermann, Towia A. ;
Sanda, Martin G. .
CLINICAL CANCER RESEARCH, 2009, 15 (18) :5794-5802
[2]   Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer [J].
Asangani, Irfan A. ;
Dommeti, Vijaya L. ;
Wang, Xiaoju ;
Malik, Rohit ;
Cieslik, Marcin ;
Yang, Rendong ;
Escara-Wilke, June ;
Wilder-Romans, Kari ;
Dhanireddy, Sudheer ;
Engelke, Carl ;
Iyer, Mathew K. ;
Jing, Xiaojun ;
Wu, Yi-Mi ;
Cao, Xuhong ;
Qin, Zhaohui S. ;
Wang, Shaomeng ;
Feng, Felix Y. ;
Chinnaiyan, Arul M. .
NATURE, 2014, 510 (7504) :278-+
[3]   MEME SUITE: tools for motif discovery and searching [J].
Bailey, Timothy L. ;
Boden, Mikael ;
Buske, Fabian A. ;
Frith, Martin ;
Grant, Charles E. ;
Clementi, Luca ;
Ren, Jingyuan ;
Li, Wilfred W. ;
Noble, William S. .
NUCLEIC ACIDS RESEARCH, 2009, 37 :W202-W208
[4]  
Borkin D., CANC CELL IN PRESS
[5]   Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gfene Expression in Castration-Resistant Prostate Cancer [J].
Cai, Changmeng ;
Wang, Hongyun ;
Xu, Youyuan ;
Chen, Shaoyong ;
Balk, Steven P. .
CANCER RESEARCH, 2009, 69 (15) :6027-6032
[6]   Interaction of MLL amino terminal sequences with menin is required for transformation [J].
Caslini, Corrado ;
Yang, Zhaohai ;
El-Osta, Mohamad ;
Milne, Thomas A. ;
Slany, Robeft K. ;
Hess, Jay L. .
CANCER RESEARCH, 2007, 67 (15) :7275-7283
[7]   Positional cloning of the gene for multiple endocrine neoplasia-type 1 [J].
Chandrasekharappa, SC ;
Guru, SC ;
Manickam, P ;
Olufemi, SE ;
Collins, FS ;
EmmertBuck, MR ;
Debelenko, LV ;
Zhuang, ZP ;
Lubensky, IA ;
Liotta, LA ;
Crabtree, JS ;
Wang, YP ;
Roe, BA ;
Weisemann, J ;
Boguski, MS ;
Agarwal, SK ;
Kester, MB ;
Kim, YS ;
Heppner, C ;
Dong, QH ;
Spiegel, AM ;
Burns, AL ;
Marx, SJ .
SCIENCE, 1997, 276 (5311) :404-407
[8]   Molecular determinants of resistance to antiandrogen therapy [J].
Chen, CD ;
Welsbie, DS ;
Tran, C ;
Baek, SH ;
Chen, R ;
Vessella, R ;
Rosenfeld, MG ;
Sawyers, CL .
NATURE MEDICINE, 2004, 10 (01) :33-39
[9]   Prostate cancer [J].
Damber, Jan-Erik ;
Aus, Gunnar .
LANCET, 2008, 371 (9625) :1710-1721
[10]   Abiraterone and Increased Survival in Metastatic Prostate Cancer [J].
De Bono, Johann S. ;
Logothetis, Christopher J. ;
Molina, Arturo ;
Fizazi, Karim ;
North, Scott ;
Chu, Luis ;
Chi, Kim N. ;
Jones, Robert J. ;
Goodman, Oscar B., Jr. ;
Saad, Fred ;
Staffurth, John N. ;
Mainwaring, Paul ;
Harland, Stephen ;
Flaig, Thomas W. ;
Hutson, Thomas E. ;
Cheng, Tina ;
Patterson, Helen ;
Hainsworth, John D. ;
Ryan, Charles J. ;
Sternberg, Cora N. ;
Ellard, Susan L. ;
Flechon, Aude ;
Saleh, Mansoor ;
Scholz, Mark ;
Efstathiou, Eleni ;
Zivi, Andrea ;
Bianchini, Diletta ;
Loriot, Yohann ;
Chieffo, Nicole ;
Thian Kheoh ;
Haqq, Christopher M. ;
Scher, Howard I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (21) :1995-2005